BUFFALO, N.Y., March 5 Charles E. Lannon was appointed as Vice-Chairman of the Board of Directors at Kinex Pharmaceuticals on March 3, 2010
Advertisement
Mr. Lannon is President of Strategic Advisory, Inc., a consulting firm specializing in the fields of health care, real estate, and start-up ventures. Since 1995, he has served on the Board of Directors for Sovran Self Storage, Inc., a publicly traded Real Estate Investment Trust (REIT), and currently holds the position of chairman of the company's governance committee. From 1982 to 1995, he was a founder and Senior Vice President of Marketing for Sovran Self Storage, Inc.
Advertisement
"Chuck has been very active in supporting Kinex since joining this Board. His business and corporate governance experience will be very helpful as Kinex escalates to the next level. We are very pleased that Chuck has accepted this position," said Johnson Y.N. Lau M.D., Executive Chairman of the Board of Directors.
About Kinex Pharmaceuticals
Kinex is a Buffalo, NY based, privately held biopharmaceutical company committed to the discovery and development of novel therapeutics. The Company's platform technologies, Mimetica(TM) and Opal(TM), provide unique insight into the design and synthesis of target-based small molecule inhibitors that selectively act on proteins that play key roles in cancer and immuno-inflammatory diseases. KX2-391 is currently being studied in a Phase 2 clinical trial in prostate cancer patients; additional Phase 2 oncology studies will commence later in 2010. KX2-361 is being developed for brain cancer; an IND is expected during the 4th quarter of 2010. In addition, Kinex is developing several other new product candidates that inhibit key immuno-inflammatory pathways.
For more information, visit www.kinexpharma.com
SOURCE Kinex Pharmaceuticals
